Back to the Top
I'd be appreciative of any advice about assessment of compliance based on drug concentrations in a PK study. Not all or our observations are at steady state.
Many thanks for your pointers.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Defining, evaluating compliance" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)